12/5
10:05 am
amgn
Amgen (NASDAQ:AMGN) was upgraded by analysts at Erste Group Bank AG from a "hold" rating to a "buy" rating.
Low
Report
Amgen (NASDAQ:AMGN) was upgraded by analysts at Erste Group Bank AG from a "hold" rating to a "buy" rating.
12/3
05:15 pm
amgn
Amgen Inc. (AMGN) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]
Low
Report
Amgen Inc. (AMGN) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]
12/3
08:05 am
amgn
Amgen (NASDAQ:AMGN) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
Low
Report
Amgen (NASDAQ:AMGN) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
12/2
03:00 am
amgn
Accord Healthcare Announces Launch of Denosumab? - Second Biosimilar in Bone Health [Globe and Mail, The (Toronto, Canada)]
Low
Report
Accord Healthcare Announces Launch of Denosumab? - Second Biosimilar in Bone Health [Globe and Mail, The (Toronto, Canada)]
12/2
02:13 am
amgn
Accord Healthcare Announces Launch of Denosumab? - Second Biosimilar in Bone Health [Yahoo! Finance]
Low
Report
Accord Healthcare Announces Launch of Denosumab? - Second Biosimilar in Bone Health [Yahoo! Finance]
11/29
11:43 pm
amgn
Is Amgen's Recent Rally Justified After Strong Clinical Trial Results? [Yahoo! Finance]
Low
Report
Is Amgen's Recent Rally Justified After Strong Clinical Trial Results? [Yahoo! Finance]
11/29
03:35 am
amgn
Low
Report
11/25
07:37 pm
amgn
IMDELLTRA's FDA Approval and Guideline Upgrade Could Be a Game Changer for Amgen (AMGN) [Yahoo! Finance]
Low
Report
IMDELLTRA's FDA Approval and Guideline Upgrade Could Be a Game Changer for Amgen (AMGN) [Yahoo! Finance]
11/25
08:05 am
amgn
Amgen (NASDAQ:AMGN) was given a new $400.00 price target on by analysts at Wells Fargo & Company.
Low
Report
Amgen (NASDAQ:AMGN) was given a new $400.00 price target on by analysts at Wells Fargo & Company.
11/25
07:19 am
amgn
Amgen (NASDAQ:AMGN) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Low
Report
Amgen (NASDAQ:AMGN) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
11/24
04:10 pm
amgn
AMGEN TO PRESENT AT CITI'S 2025 GLOBAL HEALTHCARE CONFERENCE
Low
Report
AMGEN TO PRESENT AT CITI'S 2025 GLOBAL HEALTHCARE CONFERENCE
11/24
04:00 pm
amgn
AMGEN TO PRESENT AT THE 8TH ANNUAL EVERCORE ISI HEALTHCONX CONFERENCE
Low
Report
AMGEN TO PRESENT AT THE 8TH ANNUAL EVERCORE ISI HEALTHCONX CONFERENCE
11/24
11:00 am
amgn
Amgen (NASDAQ:AMGN) is now covered by analysts at Truist Financial Corporation. They set a "hold" rating and a $318.00 price target on the stock.
Low
Report
Amgen (NASDAQ:AMGN) is now covered by analysts at Truist Financial Corporation. They set a "hold" rating and a $318.00 price target on the stock.
11/20
07:23 am
amgn
Is Amgen Inc. (NASDAQ:AMGN) A High Quality Stock To Own? [Yahoo! Finance]
Low
Report
Is Amgen Inc. (NASDAQ:AMGN) A High Quality Stock To Own? [Yahoo! Finance]
11/19
04:45 pm
amgn
FDA GRANTS FULL APPROVAL TO AMGEN'S IMDELLTRA® IN EXTENSIVE STAGE SMALL CELL LUNG CANCER [Yahoo! Finance]
Low
Report
FDA GRANTS FULL APPROVAL TO AMGEN'S IMDELLTRA® IN EXTENSIVE STAGE SMALL CELL LUNG CANCER [Yahoo! Finance]
11/19
04:01 pm
amgn
FDA GRANTS FULL APPROVAL TO AMGEN'S IMDELLTRA® IN EXTENSIVE STAGE SMALL CELL LUNG CANCER
Low
Report
FDA GRANTS FULL APPROVAL TO AMGEN'S IMDELLTRA® IN EXTENSIVE STAGE SMALL CELL LUNG CANCER
11/19
09:17 am
amgn
Amgen (NASDAQ:AMGN) had its price target raised by analysts at HSBC Holdings plc from $343.00 to $381.00. They now have a "buy" rating on the stock.
Low
Report
Amgen (NASDAQ:AMGN) had its price target raised by analysts at HSBC Holdings plc from $343.00 to $381.00. They now have a "buy" rating on the stock.
11/18
09:16 am
amgn
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Daiwa Capital Markets from $310.00 to $370.00. They now have an "outperform" rating on the stock.
Low
Report
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Daiwa Capital Markets from $310.00 to $370.00. They now have an "outperform" rating on the stock.
11/14
10:42 am
amgn
Cardiovascular Biologics Market Expected to Reach USD 4.23 Billion by 2033 Amid Advances in RNA and Biologic Therapies | DataM Intelligence [Yahoo! Finance]
Low
Report
Cardiovascular Biologics Market Expected to Reach USD 4.23 Billion by 2033 Amid Advances in RNA and Biologic Therapies | DataM Intelligence [Yahoo! Finance]
11/14
08:51 am
amgn
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Piper Sandler from $342.00 to $381.00. They now have an "overweight" rating on the stock.
Low
Report
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Piper Sandler from $342.00 to $381.00. They now have an "overweight" rating on the stock.
11/14
07:50 am
amgn
Amgen (NASDAQ:AMGN) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
Low
Report
Amgen (NASDAQ:AMGN) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
11/13
12:28 pm
amgn
Jim Cramer Shows Confidence in Amgen [Yahoo! Finance]
Low
Report
Jim Cramer Shows Confidence in Amgen [Yahoo! Finance]
11/13
09:19 am
amgn
Amgen (NASDAQ:AMGN) is now covered by analysts at Scotiabank. They set an "outperform" rating and a $385.00 price target on the stock.
Low
Report
Amgen (NASDAQ:AMGN) is now covered by analysts at Scotiabank. They set an "outperform" rating and a $385.00 price target on the stock.
11/13
05:37 am
amgn
Why Amgen Stock Was a Nearly 5% Winner Today [Yahoo! Finance]
Low
Report
Why Amgen Stock Was a Nearly 5% Winner Today [Yahoo! Finance]
11/11
02:56 pm
amgn
Jim Cramer on Amgen: “Company Announced Some Very Promising Heart Attack Prevention Results” [Yahoo! Finance]
Low
Report
Jim Cramer on Amgen: “Company Announced Some Very Promising Heart Attack Prevention Results” [Yahoo! Finance]